National survey on the effect of oncology drug shortages on cancer care

American Journal of Health-System Pharmacy

Volumn 70, Issue 7, 2013, Pages 609-617

  McBride, Ali ^a   Holle, Lisa M ^b   Westendorf, Colleen ^c   Sidebottom, Margaret ^d   Griffith, Niesha ^d   Muller, Raymond J ^e   Hoffman, James M ^c,f  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BEVACIZUMAB; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CARMUSTINE; CLOFARABINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IXABEPILONE; LEVOLEUCOVORIN; MITOXANTRONE; NAVELBINE; PACLITAXEL; PREDNISONE; TOPOTECAN; TRASTUZUMAB; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE OUTCOME; ALTERNATIVE MEDICINE; ARTICLE; BLADDER CANCER; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CLINICAL PRACTICE; COLORECTAL CANCER; DISEASE COURSE; DRUG COST; DRUG EFFICACY; DRUG SHORTAGE; DRUG TOLERABILITY; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HEADACHE; HEALTH CARE COST; HEALTH SURVEY; HEMATOLOGIC MALIGNANCY; HUMAN; KAPOSI SARCOMA; LUNG CANCER; MAINTENANCE THERAPY; MANAGED CARE; MEDICATION ERROR; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; ONCOLOGY; OVARY CANCER; PATIENT CARE; PATIENT SAFETY; PHARMACIST; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; THERAPY DELAY; UNITED STATES;

EID: 84875446644     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp120563     Document Type: Article

References (37)

1. Devi S. US drug shortages could continue for years. Lancet. 2012; 379:990-1.
2. IMS Institute for Health Informatics. Drug shortages: a closer look at products, suppliers and volume volatility. www.imshealth.com [available for purchase] (accessed 2012 Jul 5).
3. Department of Health and Human Services. A review of FDA's approach to medical product shortages. www.fda.gov/AboutFDA/ReportsManualsForms/Reports/ ucm275051.htm (accessed 2012 Nov 15).
4. Sun L. Hospitals scramble on the frontlines of drug shortages. http://articles.washingtonpost.com/2012-04-10/national/35453928-1-crucial- cancerdrugs-hospitals-scramble-acute-shortage (accessed 2012 Jul 3).
5. Harris G. U.S. scrambling to ease shortage of vital medicine. www.nytimes.com/2011/08/20/health/policy/20drug.html?pagewanted=all (accessed 2012 Jul 3).
6. Harris G. Supply of a cancer drug may run out within weeks. www.nytimes.com/2012/02/11/health/policy/supplyof-methotrexate-a-cancer-drug- mayrun-out-soon.html (accessed 2012 Jul 3).
7. Johnson PE. Drug shortages: impact and strategies. J Natl Compre Canc Netw. 2011; 9:815-9.
8. Fox ER, Birt A, James KB et al., for Expert Panel on Drug Product Shortages, American Society of Health-System Pharmacists. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health-Syst Pharm. 2009; 66:1399-406.
9. Hunnisett-Dritz D. Successful importation of cytarabine into the United States during a critical drug shortage. Am J Health-Syst Pharm. 2012; 69:1416-21.
10. Barlas S. Severe drug shortages impose heavy costs on hospital pharmacies. P & T. 2011; 36:302.
11. Institute for Safe Medication Practices. ISMP survey on drug shortages. www.ismp.org/newsletters/acutecare/articles/20100923.asp (accessed 2012 Jul 6).
12. Kaakeh R, Sweet BV, Reilly C et al. Impact of drug shortages on U.S. health systems. Am J Health-Syst Pharm. 2011; 68:1811-9.
13. American Hospital Association survey on drug shortages. www.aha.org/content/11/drugshortagesurvey.pdf (accessed 2012 Jan 13).
14. Institute for Safe Medication Practices. A shortage of everything except errors: harm associated with drug shortages. www.ismp.org/newsletters/acutecare/ showarticle.asp?id=20 (accessed 2012 Nov 15).
15. Food and Drug Administration. Frequently asked questions: temporary importation of Lipodox. www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/ UCM295225.pdf (accessed 2012 Aug 10).
16. Doxil (doxorubicin hydrochloride liposome injection) package insert. Raritan, NJ: Centocor Ortho Biotech Products, L.P.; 2011.
17. Lipodox (doxorubicin hydrochloride liposome injection) package insert. Columbia, SC: BDI Pharma, Inc.; 2012.
18. American Society of Health-System Pharmacists. Drug shortages: doxorubicin liposomal injection. www.ashp.org/DrugShortages/Current/Bulletin. aspx?id=806 (accessed 2012 Jul 5).
19. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Breast cancer, version 3.2012. www.nccn.org/professionals/ physician-gls/pdf/breast.pdf [requires registration] (accessed 2013 Jan 27).
20. Perez EA. Paclitaxel in breast cancer. Oncologist. 1998; 3:373-89. (Pubitemid 29009301)
21. American Society of Health-System Pharmacists. Drug shortages: paclitaxel injection. www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=790 (accessed 2012 Jul 5).
22. American Society of Health-System Pharmacists. Drug shortages: fluorouracil injection. www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=798 (accessed 2010 Jul 5).
23. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Colon cancer, version 3.2013 [requires registration]. www.nccn.org/professionals/physician-gls/pdf/colon.pdf(accessed 2013 Jan 27).
24. American Society of Health-System Pharmacists. Drug shortages: cytarabine injection. www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=413 (accessed 2012 Jul 5).
25. Stein R. Shortages of key drugs endanger patients. www.washingtonpost. com/national/shortages-of-key-drugsendanger-patients/2011/04/26/AF1aJJVF-story. html (accessed 2012 Jul 3).
26. Link MP, Hagerty K, Kantarjian HM. Chemotherapy drug shortages in the United States: genesis and potential solutions. J Clin Oncol. 2012; 30:692-4.
27. Gatesman ML, Smith TJ. The shortage of essential chemotherapy drugs in the United States. N Engl J Med. 2011; 365:1653-5.
28. Rabin RC. Drug scarcity's dire cost, and some ways to cope. www.nytimes.com/2011/12/13/health/policy/thepersonal-price-paid-for-shortages- ofdoxil-and-other-drugs.html (accessed 2013 Jan 27).
29. Cherici C, McGinnis P, Russell W. Buyer beware: drug shortages and the gray market. www.premierinc.com/about/news/11-aug/Gray-Market/Gray-Market- Analysis-08152011.pdf (accessed 2011 Oct 14).
30. Hoffman JM, Li E, Doloresco F et al. Projecting future drug expenditures- 2012. Am J Health-Syst Pharm. 2012; 69: 405-21.
31. Premier, Inc. Drug shortages cost U.S. care providers at least $200 million annually, pose patient safety risks, research suggests. www.premierinc.com/about/news/11-mar/drugshortage032811.jsp (accessed 2012 Jul 3).
32. BusinessWire. Independent survey of US oncologists by national analysts worldwide find drug shortages and escalating costs result in grave health consequences. www.businesswire.com/news/home/20120201005292/en/Independent- Survey-Oncologists-National-Analysts-Worldwide-Finds (accessed 2012 Jul 3).
33. Kaiser J. Shortages of cancer drugs put patients, trials at risk. Science. 2011; 332:523.
34. Goozner M. Drug shortages delay cancer clinical trials. J Natl Cancer Inst. 2012; 104:891-2.
35. Ledford H. Drug shortage slows clinical trials. www.nature.com/news/2011/ 111003/full/news.2011.570.html (accessed 2012 Jun 28).
36. Library of Congress. Bill summary & status: 112th Congress (2011-2012), S.3187. http://thomas.loc.gov/cgi-bin/bdquery/z?d112:SN03187: L&summ2=m&TOM:/bss/d112query.html (accessed 2012 Jul 16).
37. Office of Science and Data Policy, Department of Health and Human Services. Economic analysis of the causes of drug shortages. http://aspe.hhs.gov/sp/reports/2011/drugshortages/ib.pdf (accessed 2012 Nov 15).